ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
University of Chicago at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University of Chicago takes part in 7 sessions at ESMO 2026 in Madrid. Its program centres on lung cancer treatment, with additional research in urinary, breast, and head and neck cancers. It explores antibody combinations for advanced lung cancer and biomarkers linked to treatment response.
| Organization | ESMO 2026 Attendance |
|---|---|
University of Chicago Chicago, IL | |
Private research university in Chicago, Illinois, with a medical school and academic medical centre. | Abstract Fri Oct 23 13:50–14:00 Abstract Sat Oct 24 09:45–09:55 Invited Discussant LBA26, LBA96 and LBA15 Breast cancer Satellite Sat Oct 24 18:30–20:00 Pfizer - Breaking the Treatment Plateau in Advanced NSCLC: Antibody Therapy Redefined Lung & thoracic cancers Satellite Sat Oct 24 18:30–18:35 Welcome & Introductions Lung & thoracic cancers Satellite Sat Oct 24 18:50–19:15 Bispecifics and ADCs on the Horizon: Evolving the Frontline Standards Lung & thoracic cancers Satellite Sat Oct 24 19:40–19:55 Looking Ahead: The Future Puzzle of aNSCLC Treatment Lung & thoracic cancers Satellite Sun Oct 25 19:10–19:40 Redefining 1L NSCLC: Precision Medicine Beyond Actionable Genomic Alterations Lung & thoracic cancersBiomarkers & precision oncology Chair Mon Oct 26 10:15–11:45 Rapid oral: Non-metastatic NSCLC and other thoracic malignancies Lung & thoracic cancers Abstract Mon Oct 26 11:17–11:29 Invited Discussant 4155RO, 4156RO and 4158RO Lung & thoracic cancers Poster Mon Oct 26 12:00–12:45 Abstract Mon Oct 26 15:33–15:43 |
Find decision makers at University of Chicago
Tell us what you sell and we’ll find the people at University of Chicago most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction